Journal of the American Association of Nurse Practitioners · 2015 · 10 citations · 4 references
MedicineHealth SciencesHematologyIron Metabolism DisordersMedical GeneticsTransfusion MedicineAnemiaIron DeficiencyIron HomeostasisSickle Cell DiseaseTransfusional Iron OverloadAdult Transfusional Iron OverloadIron Overload PathophysiologyIron Overload SyndromesSickle Cell AnemiaSickle Cell Disease Transfusion TherapyTransfusion-related Iron Overload
OBJECTIVE: To assess the prevalence of iron overload in adults with sickle cell disease (SCD) not on a chronic transfusion protocol. DESIGN: Retrospective chart review. DATA SOURCE: University of South Alabama Comprehensive Sickle Cell Center adult outpatient clinic. RESULTS: There was no significant difference in units transfused across the four genotypes (HbSS, HbSC, HbSβ(0)-thalassemia, and HbSβ(+)-thalassemia). Only individuals with HbSS (n = 63) met criteria for iron overload with ferritins of ≥1500 ng/mL. Forty-eight had ferritins <1500 ng/mL, eight (13%) had ferritins ≥3000 ng/mL, and seven (11%) had ferritins ≥1500 and <3000 ng/mL. The overall prevalence of iron overload was 9.74% in SCD cohort and 23.8% in the HbSS genotype. CONCLUSIONS: Our data support that patients with HbSS are at a particularly high risk for inadvertent iron overload as compared to HbSC, HbSβ(0)-thalassemia, and HbSβ(+)-thalassemia. IMPLICATIONS FOR PRACTICE: This study supports the need for healthcare providers to closely monitor the number of red blood cell (RBC) transfusions, RBC units transfused, and serial baseline, steady-state ferritin levels. With closer monitoring, the clinical significance of iron overload in SCD can be established and guide the healthcare provider's management in the prevention of iron overload.
4
Survival in Medically Treated Patients with Homozygous β-Thalassemia
Nancy F. Olivieri, David G. Nathan, James H. MacMillan et al. · New England Journal of Medicine · 1994 · 864 citations · Full text
Medicine, Cardiology, Hematology +15
Indications for red cell transfusion in sickle cell disease
Kwaku Ohene‐Frempong · Seminars in Hematology · 2001 · 88 citations
Medicine, Hematology, Hemodialysis +13